Lifecore Biomedical, Inc.
LFCR · NASDAQ
9/30/2025 | 5/25/2025 | 2/23/2025 | 11/24/2024 | |
|---|---|---|---|---|
| Revenue | $31 | $36 | $35 | $33 |
| % Growth | -14.6% | 3.7% | 8% | – |
| Cost of Goods Sold | $23 | $22 | $25 | $21 |
| Gross Profit | $8 | $14 | $10 | $11 |
| % Margin | 25% | 38.4% | 28% | 34% |
| R&D Expenses | $2 | $2 | $2 | $2 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9 | $9 | $10 | $11 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2 | $7 | $0 |
| Operating Expenses | $11 | $9 | $19 | $13 |
| Operating Income | -$3 | $5 | -$9 | -$2 |
| % Margin | -9.9% | 14.6% | -25.7% | -6% |
| Other Income/Exp. Net | -$7 | -$6 | -$6 | -$5 |
| Pre-Tax Income | -$10 | -$1 | -$15 | -$7 |
| Tax Expense | $0 | $0 | -$0 | $0 |
| Net Income | -$10 | -$1 | -$15 | -$7 |
| % Margin | -32.1% | -3.1% | -42% | -20.2% |
| EPS | -0.29 | -0.055 | -0.47 | -0.25 |
| % Growth | -424.4% | 88.2% | -88% | – |
| EPS Diluted | -0.29 | -0.055 | -0.47 | -0.25 |
| Weighted Avg Shares Out | 37 | 37 | 37 | 34 |
| Weighted Avg Shares Out Dil | 37 | 37 | 37 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $6 | $5 | $5 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$7 | $6 | -$7 | $1 |
| % Margin | -22.9% | 17.3% | -20.5% | 3% |